Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023891 · ClinicalTrials.gov registry record · Phase 1
Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids
A Phase 1 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT03023891 is a Phase 1 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT03023891, a Phase 1 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study evaluates the effect of acute administration of oral prednisone in white blood cells counts and glucose tolerance and the relationship of these measures with changes in gene expression in healthy volunteers. White blood cells counts, glucose tolerance and gene expression will be study before and after prednisone administration.
Interventions
- DRUG Prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03023891
The ClinicalTrials.gov registry entry for NCT03023891 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prednisone is the first listed.
NCT03023891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03023891 about?
NCT03023891 is a clinical study titled "Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids". This study evaluates the effect of acute administration of oral prednisone in white blood cells counts and glucose tolerance and the relationship of these measures with changes in gene expression in healthy volunteers. White blood cells counts, glucose tolerance and gene expression will be study bef...
What is the current status of trial NCT03023891?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2017-02-15. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03023891?
The interventions under investigation include: Prednisone (DRUG).
Who is sponsoring clinical trial NCT03023891?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.